Originally Published MX January/February
Originally Published MX January/February 2003
Interview by Steve Halasey
|Martin D. Madaus,
president and CEO
of Roche Diagnostics,
in the market--
and in the boardroom.
not just on the bottom line. Company leadership can influence the direction of a
and its investors,
making available resources that would otherwise have gone into other sectors or
industries. And personal leadership can encourage companies to take on
challenges well beyond those of an already competitive marketplace.
But don't take our word for it. Ask Martin D. Madaus, president and CEO of Roche Diagnostics Corp. (Indianapolis), the leader in the global market for in vitro diagnostics (IVDs). Rising through the ranks at Boehringer Mannheim (acquired by Roche in 1997), Madaus took over the helm of the company in January 2000. He arrived with a clear notion of the kind of company he wanted to lead, and rapidly set about putting his changes in motion.
Madaus's efforts have paid off in the company's bottom line--and elsewhere. During the past year, Roche has repeatedly grabbed top honors at a wide variety of awards presentations. In December, the company's e-business unit received